GlycoMimetics Inc | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (34)

View All

Latest Posts

About This Stock More About This Stock
GlycoMimetics: A Potential Game Changer In Blood Cancers With Near-Term Catalysts
Article By: Scott Matusow
Thursday, March 21, 2024 2:25 AM EDT
Glycomimetics' Uproleselan is expected to read out data in relapsed/refractory and elderly newly diagnosed Acute Myeloid Leukemia (AML) after 6 years in pivotal studies.
In this article: GLYC Also: ABBV
Read
GlycoMimetics: A Breakthrough In Hematopoietic Stem Cell Transplantation
Article By: Scott Matusow
Tuesday, May 9, 2023 1:35 PM EDT
Blood cancers such as AML, MM, and MDS affect a terrible toll on patients and their loved ones. Glycomimetics may be such a company that can offer patients suffering from various blood cancers hope with Hematopoietic Stem Cell Transplantation.
In this article: GLYC Also: ABBV, PFE, JAZZ
Read
GlycoMimetics Audio Discussion And Analysis With Dan Cohen And Scott Matusow
Podcast By: Scott Matusow
Monday, February 13, 2023 3:30 AM EDT
Dan Cohen and Scott Matusow discuss In this 1:11 audio the upcoming data sets for Glycomimetics. We talk about The Company's platform chemistry in depth, and give our predictions for success/failure of said data.
In this podcast: GLYC Also: ABBV, JAZZ
Listen
Week In Review: Four China Biopharmas Announce $100+ Million Deals In First Week Of 2020
Article By: ChinaBio® Today
Saturday, January 11, 2020 4:11 PM EDT
Apollomics of Hangzhou announced a $189 million agreement to develop two GlycoMimetics novel E-selectin-based immunotherapies in China for leukemia. Apollomics will be responsible for developing uproleselan and GMI-1687.
In this article: LLY, GLYC, BPMC, ZLAB
Read
Late Slide In Tech Mega-Caps Leaves Averages Mixed For Week
Article By: The Fly
Saturday, June 10, 2017 10:38 AM EDT
Stocks appeared in line for a slight weekly advance until Friday afternoon, when a sharp decline in a number of mega-cap tech stock pushed the Nasdaq down nearly 2.5% at its low point.
In this article: DFT, DHI, DLR, FOR, JWN, M, THO, VZ, CLDR, AMRI, GIII, NLNK, AAPL, AMZN, FRAN, GOOG, MSFT, YHOO, DVAX, JUNO, BABA, META, AMBA, GLYC, KITE, BLUE, MIK, ANTM, PLAY, RDUS, LOXO, DLTH, HDS
Read
All Posts

Latest Tweets for $GLYC

No tweets yet!

PARTNER HEADLINES

$GLYC

Comments Status Updates
Week In Review: OrbiMed Raises $800 Million For Its Fourth Asia Fund
Alpha Stockman • 3/9/2021 1:01:53 AM

What does this mean for $GLYC?

1 to 1 of 1 comments